⌘K

Login Start Free

Home/Filings/4/0000950170-24-130592

4//SEC Filing

Mulroy Michael H. 4

Accession 0000950170-24-130592

CIK 0000876343other

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:30 PM ET

Size

4.4 KB

Accession

0000950170-24-130592

Insider Transaction Report

Form 4

Period: 2024-11-22

Lineage Cell Therapeutics, Inc.LCTX

Mulroy Michael H.

Director

Transactions

Purchase
Common Shares
2024-11-22$0.57/sh+40,000$22,640→ 298,555 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1

filerCIK 0001509725

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 4:30 PM ET
Size: 4.4 KB

View on SEC.gov